Insider · CIK 0001573840
Carol A O'Donnell
Files at SOTK (SONO TEK CORP), APUS (Apimeds Pharmaceuticals US, Inc.). First filing -, latest -.
In brief
Carol A O'Donnell files SEC Form 4 as director at SOTK (SONO TEK CORP), and also at APUS (Apimeds Pharmaceuticals US, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Carol A O'Donnell has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 20, 2026 | SOTK SONO TEK CORP | AGrant or award Sono-Tek Optionsderivative | +5,396 | $5.35 | $29k | 30,773 | Aug 24, 2026 |
| Nov 11, 2025 | APUS Apimeds Pharmaceuticals US, Inc. | AGrant or award Stock Option (right to buy)derivative | +10,000 | $0.00 | $0 | 10,000 | Nov 13, 2025 |
| Oct 15, 2025 | APUS Apimeds Pharmaceuticals US, Inc. | AGrant or award Stock Option (right to buy)derivative | +3,000 | $0.00 | $0 | 3,000 | Oct 21, 2025 |
| Aug 21, 2025 | SOTK SONO TEK CORP | AGrant or award Sono-Tek Optionsderivative | +7,018 | $3.25 | $23k | 25,377 | Aug 25, 2025 |
| May 16, 2025 | APUS Apimeds Pharmaceuticals US, Inc. | AGrant or award Stock Option (right to buy)derivative | +5,780 | $0.00 | $0 | 5,780 | May 20, 2025 |
Questions about Carol A O'Donnell
Answered from the filings on this page, as of the latest one.
Is Carol A O'Donnell buying or selling?
Carol A O'Donnell has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Carol A O'Donnell's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Carol A O'Donnell has 0.
Where does Carol A O'Donnell file Form 4?
Carol A O'Donnell has filed Form 4 at SOTK (SONO TEK CORP); APUS (Apimeds Pharmaceuticals US, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.